| abstract |
The present invention relates to field of medicaments, the in particular to new opplication of glycyrrhizic acid, especially inhibit the application in the relevant a variety of neurodegenerative disease drugs of neuroinflamation in preparation.The present invention, which is experimentally confirmed glycyrrhizic acid, effectively to inhibit the release of inflammatory factor, to reduce it to degree of injury caused by neuronal cell, improve the cognitive function of brain tissue.The above result shows that glycyrrhizic acid can be used for preparing neuroinflamation inhibitor and treatment medicine for senile dementia. |